yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q48520042-73FB476A-8023-45E1-AF28-F4507FECB084
Q48520042-73FB476A-8023-45E1-AF28-F4507FECB084
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48520042-73FB476A-8023-45E1-AF28-F4507FECB084
Cost-effectiveness of evolocumab in treatment of heterozygous familial hypercholesterolaemia in Bulgaria: measuring health benefit by effectively treated patient-years.
P2860
Q48520042-73FB476A-8023-45E1-AF28-F4507FECB084
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48520042-73FB476A-8023-45E1-AF28-F4507FECB084
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a5b47e7a47835277ae6a539b2488f9b467338ee
P2860
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.